This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Jan 4;2(1):e186839.

doi: 10.1001/jamanetworkopen.2018.6839.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Safety Is Only Half of the Story

Margaret E Smith^{1

2}, Hari Nathan^{1

2}

Affiliations

PMID: 30646199
DOI: 10.1001/jamanetworkopen.2018.6839

Free article

Comment

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Safety Is Only Half of the Story

Margaret E Smith et al. JAMA Netw Open. 2019.

Free article

. 2019 Jan 4;2(1):e186839.

doi: 10.1001/jamanetworkopen.2018.6839.

Authors

Margaret E Smith^{1

2}, Hari Nathan^{1

2}

Affiliations

¹ Department of Surgery, University of Michigan, Ann Arbor.
² Center for Healthcare Outcomes and Policy, Ann Arbor, Michigan.

PMID: 30646199
DOI: 10.1001/jamanetworkopen.2018.6839

No abstract available

PubMed Disclaimer

Comment on

Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures.
Foster JM, Sleightholm R, Patel A, Shostrom V, Hall B, Neilsen B, Bartlett D, Smith L. Foster JM, et al. JAMA Netw Open. 2019 Jan 4;2(1):e186847. doi: 10.1001/jamanetworkopen.2018.6847. JAMA Netw Open. 2019. PMID: 30646202 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information